HS3ST3B1
Basic information
Region (hg38): 17:14301081-14349404
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HS3ST3B1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 0 | 3 |
Variants in HS3ST3B1
This is a list of pathogenic ClinVar variants found in the HS3ST3B1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-14301523-G-T | not specified | Uncertain significance (Oct 25, 2023) | ||
17-14301535-G-C | not specified | Uncertain significance (Dec 19, 2023) | ||
17-14301540-G-C | not specified | Uncertain significance (May 28, 2024) | ||
17-14301551-C-T | Benign (May 21, 2018) | |||
17-14301552-C-T | not specified | Uncertain significance (May 30, 2024) | ||
17-14301559-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
17-14301571-T-A | Benign (Jul 16, 2018) | |||
17-14301618-G-C | not specified | Uncertain significance (Dec 21, 2022) | ||
17-14301633-A-G | not specified | Uncertain significance (Dec 09, 2023) | ||
17-14301687-G-T | not specified | Uncertain significance (Jun 18, 2021) | ||
17-14301718-G-T | not specified | Uncertain significance (Mar 16, 2024) | ||
17-14301753-A-T | not specified | Uncertain significance (Sep 06, 2022) | ||
17-14301778-G-C | not specified | Uncertain significance (Dec 19, 2023) | ||
17-14301790-G-T | not specified | Uncertain significance (Aug 17, 2022) | ||
17-14301820-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
17-14301829-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
17-14301846-A-T | not specified | Uncertain significance (Aug 12, 2021) | ||
17-14301850-C-G | not specified | Uncertain significance (Jan 06, 2023) | ||
17-14301851-G-A | Benign (Dec 31, 2019) | |||
17-14301916-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
17-14301939-A-G | not specified | Uncertain significance (Oct 03, 2022) | ||
17-14301985-T-G | not specified | Uncertain significance (Dec 17, 2023) | ||
17-14302037-C-G | not specified | Uncertain significance (Feb 27, 2023) | ||
17-14345080-A-G | not specified | Uncertain significance (Jul 19, 2023) | ||
17-14345096-G-C | not specified | Uncertain significance (Nov 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HS3ST3B1 | protein_coding | protein_coding | ENST00000360954 | 2 | 48322 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.293 | 0.688 | 123495 | 0 | 5 | 123500 | 0.0000202 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.458 | 223 | 243 | 0.917 | 0.0000146 | 2490 |
Missense in Polyphen | 68 | 91.246 | 0.74524 | 982 | ||
Synonymous | 0.626 | 109 | 118 | 0.927 | 0.00000755 | 829 |
Loss of Function | 1.98 | 2 | 8.09 | 0.247 | 3.45e-7 | 99 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000502 | 0.0000449 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) to catalyze the transfer of a sulfo group to an N- unsubstituted glucosamine linked to a 2-O-sulfo iduronic acid unit on heparan sulfate. Catalyzes the O-sulfation of glucosamine in IdoUA2S-GlcNS and also in IdoUA2S-GlcNH2. The substrate-specific O-sulfation generates an enzyme-modified heparan sulfate which acts as a binding receptor to Herpes simplex virus-1 (HSV-1) and permits its entry. Unlike 3-OST-1, does not convert non- anticoagulant heparan sulfate to anticoagulant heparan sulfate. {ECO:0000269|PubMed:10520990}.;
- Pathway
- Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);Metapathway biotransformation Phase I and II;Metabolism of carbohydrates;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Glycosaminoglycan metabolism;heparan sulfate biosynthesis (late stages);heparan sulfate biosynthesis;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.111
Haploinsufficiency Scores
- pHI
- 0.182
- hipred
- N
- hipred_score
- 0.321
- ghis
- 0.423
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.274
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hs3st3b1
- Phenotype
Gene ontology
- Biological process
- glycosaminoglycan biosynthetic process;protein sulfation;heparan sulfate proteoglycan biosynthetic process;heparan sulfate proteoglycan biosynthetic process, enzymatic modification
- Cellular component
- Golgi membrane;integral component of plasma membrane
- Molecular function
- [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity;[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity;heparan sulfate sulfotransferase activity